These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND XPO1, DKFZp686B1823, 7514, ENSG00000082898, O14980, CRM1
26 results:

  • 1. The nuclear export protein exportin-1 in solid malignant tumours: From biology to clinical trials.
    Lai C; Xu L; Dai S
    Clin Transl Med; 2024 May; 14(5):e1684. PubMed ID: 38783482
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Discovery of Aminoratjadone Derivatives as Potent Noncovalent crm1 Inhibitors.
    Jian L; Zscherp R; Beutling U; Shen X; Xu S; Zhang X; Brönstrup M; Klahn P; Sun Q
    J Med Chem; 2023 Sep; 66(17):11940-11950. PubMed ID: 37595020
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Nuclear export of BATF2 enhances colorectal cancer proliferation through binding to crm1.
    Zhou J; Lei Z; Chen J; Liao S; Chen Y; Liu C; Huang S; Li L; Zhang Y; Wang P; Huang Y; Li J; Liang H
    Clin Transl Med; 2023 May; 13(5):e1260. PubMed ID: 37151195
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. O-GlcNAcylation promotes the cytosolic localization of the m
    Li J; Ahmad M; Sang L; Zhan Y; Wang Y; Yan Y; Liu Y; Mi W; Lu M; Dai Y; Zhang R; Dong MQ; Yang YG; Wang X; Sun J; Li J
    J Biol Chem; 2023 Jun; 299(6):104738. PubMed ID: 37086786
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Mutational analysis of microsatellite-stable gastrointestinal cancer with high tumour mutational burden: a retrospective cohort study.
    Wang J; Xiu J; Farrell A; Baca Y; Arai H; Battaglin F; Kawanishi N; Soni S; Zhang W; Millstein J; Shields AF; Grothey A; Weinberg BA; Marshall JL; Lou E; Khushman M; Sohal DPS; Hall MJ; Liu T; Oberley M; Spetzler D; Korn WM; Shen L; Lenz HJ
    Lancet Oncol; 2023 Feb; 24(2):151-161. PubMed ID: 36681091
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Sequential Administration of xpo1 and ATR Inhibitors Enhances Therapeutic Response in TP53-mutated colorectal cancer.
    Inoue A; Robinson FS; Minelli R; Tomihara H; Rizi BS; Rose JL; Kodama T; Srinivasan S; Harris AL; Zuniga AM; Mullinax RA; Ma X; Seth S; Daniele JR; Peoples MD; Loponte S; Akdemir KC; Khor TO; Feng N; Roszik J; Sobieski MM; Brunell D; Stephan C; Giuliani V; Deem AK; Shingu T; Deribe YL; Menter DG; Heffernan TP; Viale A; Bristow CA; Kopetz S; Draetta GF; Genovese G; Carugo A
    Gastroenterology; 2021 Jul; 161(1):196-210. PubMed ID: 33745946
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Association of xpo1 Overexpression with NF-κB and Ki67 in colorectal cancer.
    Aladhraei M; Kassem Al-Thobhani A; Poungvarin N; Suwannalert P
    Asian Pac J Cancer Prev; 2019 Dec; 20(12):3747-3754. PubMed ID: 31870117
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. SET1A-Mediated Mono-Methylation at K342 Regulates YAP Activation by Blocking Its Nuclear Export and Promotes Tumorigenesis.
    Fang L; Teng H; Wang Y; Liao G; Weng L; Li Y; Wang X; Jin J; Jiao C; Chen L; Peng X; Chen J; Yang Y; Fang H; Han D; Li C; Jin X; Zhang S; Liu Z; Liu M; Wei Q; Liao L; Ge X; Zhao B; Zhou D; Qin HL; Zhou J; Wang P
    Cancer Cell; 2018 Jul; 34(1):103-118.e9. PubMed ID: 30008322
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. MicroRNA-192-5p is a predictive biomarker of survival for Stage IIIB colon cancer patients.
    Li P; Ou Q; Braciak TA; Chen G; Oduncu FS
    Jpn J Clin Oncol; 2018 Jul; 48(7):619-624. PubMed ID: 29529220
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Nuclear Export of Ubiquitinated Proteins Determines the Sensitivity of colorectal cancer to Proteasome Inhibitor.
    Wu T; Chen W; Zhong Y; Hou X; Fang S; Liu CY; Wang G; Yu T; Huang YY; Ouyang X; Li HQ; Cui L; Yang Y
    Mol Cancer Ther; 2017 Apr; 16(4):717-728. PubMed ID: 27903750
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. First-line treatment with FOLFOXIRI for advanced pancreatic cancer in clinical practice: Patients' outcome and analysis of prognostic factors.
    Vivaldi C; Caparello C; Musettini G; Pasquini G; Catanese S; Fornaro L; Lencioni M; Falcone A; Vasile E
    Int J Cancer; 2016 Aug; 139(4):938-45. PubMed ID: 27038273
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Cytoplasmic localization of Nrf2 promotes colorectal cancer with more aggressive tumors via upregulation of PSMD4.
    Lin PL; Chang JT; Wu DW; Huang CC; Lee H
    Free Radic Biol Med; 2016 Jun; 95():121-32. PubMed ID: 27033953
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. xpo1 Inhibition Enhances Radiation Response in Preclinical Models of Rectal cancer.
    Ferreiro-Neira I; Torres NE; Liesenfeld LF; Chan CH; Penson T; Landesman Y; Senapedis W; Shacham S; Hong TS; Cusack JC
    Clin Cancer Res; 2016 Apr; 22(7):1663-73. PubMed ID: 26603256
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Novel reversible selective inhibitor of nuclear export shows that crm1 is a target in colorectal cancer cells.
    Niu M; Chong Y; Han Y; Liu X
    Cancer Biol Ther; 2015; 16(7):1110-8. PubMed ID: 25996664
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Histopathological predictors for local recurrence in patients with T3 and T4 rectal cancers without preoperative chemoradiotherapy.
    Akagi Y; Hisaka T; Mizobe T; Kinugasa T; Ogata Y; Shirouzu K
    J Surg Oncol; 2014 Nov; 110(6):739-44. PubMed ID: 24962179
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Characterization of BARD1 targeting and dynamics at the centrosome: the role of crm1, BRCA1 and the Q564H mutation.
    Brodie KM; Mok MTS; Henderson BR
    Cell Signal; 2012 Feb; 24(2):451-459. PubMed ID: 21982881
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Nuclear APC.
    Neufeld KL
    Adv Exp Med Biol; 2009; 656():13-29. PubMed ID: 19928349
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. SUMOylation regulates nuclear localization of Krüppel-like factor 5.
    Du JX; Bialkowska AB; McConnell BB; Yang VW
    J Biol Chem; 2008 Nov; 283(46):31991-2002. PubMed ID: 18782761
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. The survivin isoform survivin-3B is cytoprotective and can function as a chromosomal passenger complex protein.
    Knauer SK; Bier C; Schlag P; Fritzmann J; Dietmaier W; Rödel F; Klein-Hitpass L; Kovács AF; Döring C; Hansmann ML; Hofmann WK; Kunkel M; Brochhausen C; Engels K; Lippert BM; Mann W; Stauber RH
    Cell Cycle; 2007 Jun; 6(12):1502-9. PubMed ID: 17582222
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Nuclear export is essential for the tumor-promoting activity of survivin.
    Knauer SK; Krämer OH; Knösel T; Engels K; Rödel F; Kovács AF; Dietmaier W; Klein-Hitpass L; Habtemichael N; Schweitzer A; Brieger J; Rödel C; Mann W; Petersen I; Heinzel T; Stauber RH
    FASEB J; 2007 Jan; 21(1):207-16. PubMed ID: 17099069
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.